Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Scienture Holdings, Inc. (SCNX : NSDQ)

• Company Description    Scienture Holdings Inc., through its wholly owned subsidiaries, Scienture and Integra Pharma Solutions, LLC, is a comprehensive pharmaceutical product company focused on providing enhanced value to patients, physicians and caregivers by offering novel specialty products to satisfy unmet market needs. Scienture Holdings Inc., formerly known as TRxADE Health Inc., is based in TAMPA, FL. Number of Employees: 19

• Price / Volume Information    Yesterday's Closing Price: $0.55 Daily Weekly Monthly 20 Day Moving Average: 1,645,803 shares Shares Outstanding: 40.63 (millions) Market Capitalization: $22.35 (millions) Beta: 2.95 52 Week High: $8.19 52 Week Low: $0.46 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -6.37% -8.35% 12 Week -36.36% -37.50% Year To Date -90.91% -92.16%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 20 Austin Blvd. - Commack,NY 11725 USA ph: 631-670-6039 fax: 800-265-6932 ir@scienture.com https://scienture.com

• General Corporate Information    Officers Surendra Ajjarapu - Chairman and Chief Executive Officer Prashant Patel - President and Chief Operating Officer Eric Sherb - Chief Financial Officer Donald G. Fell - Director Mayur Doshi - Director Peer Information Scienture Holdings, Inc. (GSAC) Scienture Holdings, Inc. (CASI) Scienture Holdings, Inc. (ALCD.) Scienture Holdings, Inc. (OMNN) Scienture Holdings, Inc. (CGPI.) Scienture Holdings, Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 80880X104 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/24/26 Share - Related Items Shares Outstanding: 40.63 Most Recent Split Date: 6.00 (0.07:1) Beta: 2.95 Market Capitalization: $22.35 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/24/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.23 Price/Cash Flow: - Price / Sales: 151.94 EPS Growth vs. Year Ago Period: 85.82% vs. Previous Quarter: 60.42% Sales Growth vs. Year Ago Period: 807.69% vs. Previous Quarter: -% ROE 09/30/25 - -25.18 06/30/25 - -24.47 03/31/25 - -22.57 ROA 09/30/25 - -19.22 06/30/25 - -19.30 03/31/25 - -18.12 Current Ratio 09/30/25 - 0.19 06/30/25 - 0.11 03/31/25 - 1.05 Quick Ratio 09/30/25 - 0.16 06/30/25 - 0.11 03/31/25 - 1.05 Operating Margin 09/30/25 - - 06/30/25 - - 03/31/25 - -9,865.18 Net Margin 09/30/25 - - 06/30/25 - - 03/31/25 - -10,364.22 Pre-Tax Margin 09/30/25 - -3,174.02 06/30/25 - -15,853.78 03/31/25 - -10,341.10 Book Value 09/30/25 - 2.40 06/30/25 - 5.94 03/31/25 - 6.49 Inventory Turnover 09/30/25 - 1.28 06/30/25 - 61.30 03/31/25 - 39.16 Debt-to-Equity 09/30/25 - 0.00 06/30/25 - 0.02 03/31/25 - 0.01 Debt-to-Capital 09/30/25 - 0.00 06/30/25 - 1.99 03/31/25 - 1.33

Powered by Zacks Investment Research ©